Chen Zhan
Guangzhou Medical University
21 Papers
7 Citations
Chen Zhan is an academic researcher from Guangzhou Medical University. The author has contributed to research in topics: Medicine & Eosinophilic bronchitis. The author has an hindex of 5, co-authored 14 publications.
Chat about Author
Papers
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China.
Ruchong Chen,Wenhua Liang,Mei Jiang,Wei-jie Guan,Chen Zhan,Tao Wang,Chun-Li Tang,Ling Sang,Jiaxing Liu,Zhengyi Ni,Yu Hu,Lei Liu,Hong Shan,Chunliang Lei,Yi-xiang Peng,Li Wei,Yong Liu,Ya-hua Hu,Peng Peng,Jian-ming Wang,Ji-yang Liu,Zhong Chen,Gang Li,Zhi-jian Zheng,Shao-qin Qiu,Jie Luo,Chang-jiang Ye,Shao-yong Zhu,Xiaoqing Liu,Linling Cheng,Feng Ye,Jinping Zheng,Nuofu Zhang,Yimin Li,Jianxing He,Shiyue Li,Nanshan Zhong +36 more
TL;DR: The proposed nomogram accurately predict clinical outcomes of patients with COVID-19 based on individual characteristics and has sufficient discriminatory power with the C-index of 0.91.
657
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China.
Yaping Wang,Ruchong Chen,Fengyu Hu,Yun Lan,Zhaowei Yang,Chen Zhan,Jingrong Shi,Xizi Deng,Mei Jiang,Shuxin Zhong,Baolin Liao,Kai Deng,Jingyan Tang,Liliangzi Guo,Mengling Jiang,Qinghong Fan,Meiyu Li,Jinxin Liu,Yaling Shi,Xilong Deng,Xincai Xiao,Min Kang,Yan Li,Wei-jie Guan,Yimin Li,Shiyue Li,Feng Li,Nanshan Zhong,Xiaoping Tang +28 more
TL;DR: In this article, the authors reported the epidemiological, viral, and clinical characteristics of hospitalized patients infected with the Delta variant of concern (VOC), also known as lineage B. The whole chain of the Delta VOC transmission was described and compared with a cohort of wild-type infection in 2020 admitted to the Guangzhou Eighth People's Hospital.
213
Short-term outcomes of COVID-19 and risk factors for progression.
Li Long,Xiansheng Zeng,Xu Zhang,Wei Xiao,E Guo,Wenzhi Zhan,Xuejiao Yang,Chunyan Li,Caiyun Wu,Tingting Xu,Chen Zhan,Yuehan Chen,Mei Jiang,Nanshan Zhong,Kefang Lai +14 more
TL;DR: This study aimed to investigate short-term outcomes of patients rated with different severities on admission, and to identify risk factors for progression, thereby helping the management of COVID-19 in clinical practice.
71
Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma
Fang Yi,Chen Zhan,Baojuan Liu,Hu Li,Jianmeng Zhou,Jiaman Tang,Wen Peng,Wei Lu,Qiaoli Chen,Kefang Lai +9 more
TL;DR: In this paper , the efficacy of montelukast alone, budesonide/formoterol alone and the combination of both in the treatment of CVA was investigated and compared with inhaled corticosteroids and long-acting β2-agonist (ICS/LABA).
Risk factors for impaired pulmonary diffusion function in convalescent COVID-19 patients: A systematic review and meta-analysis
Haopeng Zhi,Xiaolong Ji,Zi-Nan Zhao,H. Liang,Shuxin Zhong,Yiting Luo,Mi-Na Zhong,Chen Zhan,Yi Gao,Xilong Deng,Shiyue Li,Jing Li,Nanshan Zhong,Mei Jiang,Ruchong Chen +14 more
TL;DR: Wang et al. as discussed by the authors conducted a meta-analysis of the potential risk factors for impaired diffusing capacity for carbon monoxide (DLCO) in convalescent COVID-19 patients.
14